25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Axonics Inc
Buy, Hold or Sell?

Let's analyze Axonics together

I guess you are interested in Axonics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Axonics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Axonics Inc

I send you an email if I find something interesting about Axonics Inc.

Quick analysis of Axonics (30 sec.)










What can you expect buying and holding a share of Axonics? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€11.32
Expected worth in 1 year
€12.23
How sure are you?
57.9%

+ What do you gain per year?

Total Gains per Share
€0.91
Return On Investment
1.5%

For what price can you sell your share?

Current Price per Share
€59.50
Expected price per share
€58.50 - €62.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Axonics (5 min.)




Live pricePrice per Share (EOD)

€59.50

Intrinsic Value Per Share

€9.43 - €11.47

Total Value Per Share

€20.75 - €22.79

2. Growth of Axonics (5 min.)




Is Axonics growing?

Current yearPrevious yearGrowGrow %
How rich?$627.1m$533.5m$85.4m13.8%

How much money is Axonics making?

Current yearPrevious yearGrowGrow %
Making money-$3.9m-$11.5m$7.5m190.1%
Net Profit Margin-4.7%-16.6%--

How much money comes from the company's main activities?

3. Financial Health of Axonics (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Axonics? (5 min.)

Welcome investor! Axonics's management wants to use your money to grow the business. In return you get a share of Axonics.

What can you expect buying and holding a share of Axonics?

First you should know what it really means to hold a share of Axonics. And how you can make/lose money.

Speculation

The Price per Share of Axonics is €59.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Axonics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Axonics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €11.32. Based on the TTM, the Book Value Change Per Share is €0.23 per quarter. Based on the YOY, the Book Value Change Per Share is €0.51 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Axonics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.37-0.6%-0.020.0%-0.16-0.3%-0.25-0.4%-0.25-0.4%
Usd Book Value Change Per Share-0.21-0.3%0.250.4%0.550.9%0.651.1%0.651.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.21-0.3%0.250.4%0.550.9%0.651.1%0.651.1%
Usd Price Per Share68.41-59.28-62.89-50.94-50.94-
Price to Earnings Ratio-45.65-105.34-321.57-70.79-70.79-
Price-to-Total Gains Ratio-333.48-44.94-124.28--50.90--50.90-
Price to Book Ratio5.57-4.88-6.07-6.64-6.64-
Price-to-Total Gains Ratio-333.48-44.94-124.28--50.90--50.90-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share64.6051
Number of shares15
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.250.65
Usd Total Gains Per Share0.250.65
Gains per Quarter (15 shares)3.719.70
Gains per Year (15 shares)14.8538.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1015503929
20302007868
3045350116107
4059500155146
5074650194185
6089800233224
70104950272263
801191100311302
901341250349341
1001481400388380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%5.07.00.041.7%5.014.00.026.3%5.014.00.026.3%5.014.00.026.3%
Book Value Change Per Share3.01.00.075.0%7.05.00.058.3%11.08.00.057.9%11.08.00.057.9%11.08.00.057.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.019.00.0%0.00.019.00.0%0.00.019.00.0%
Total Gains per Share3.01.00.075.0%7.05.00.058.3%11.08.00.057.9%11.08.00.057.9%11.08.00.057.9%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Axonics

About Axonics Inc

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Fundamental data was last updated by Penke on 2024-07-24 17:58:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Axonics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Axonics earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • A Net Profit Margin of -20.9% means that €-0.21 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Axonics Inc:

  • The MRQ is -20.9%. The company is making a huge loss. -2
  • The TTM is -4.7%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-20.9%TTM-4.7%-16.3%
TTM-4.7%YOY-16.6%+12.0%
TTM-4.7%5Y-142.1%+137.5%
5Y-142.1%10Y-142.1%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.9%-12.9%-8.0%
TTM-4.7%-15.4%+10.7%
YOY-16.6%-13.3%-3.3%
5Y-142.1%-20.1%-122.0%
10Y-142.1%-23.9%-118.2%
1.1.2. Return on Assets

Shows how efficient Axonics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • -2.7% Return on Assets means that Axonics generated €-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Axonics Inc:

  • The MRQ is -2.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.7%TTM-0.6%-2.1%
TTM-0.6%YOY-2.0%+1.4%
TTM-0.6%5Y-4.1%+3.6%
5Y-4.1%10Y-4.1%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.7%-3.6%+0.9%
TTM-0.6%-3.8%+3.2%
YOY-2.0%-3.6%+1.6%
5Y-4.1%-3.4%-0.7%
10Y-4.1%-4.0%-0.1%
1.1.3. Return on Equity

Shows how efficient Axonics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • -3.0% Return on Equity means Axonics generated €-0.03 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Axonics Inc:

  • The MRQ is -3.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.0%TTM-0.6%-2.4%
TTM-0.6%YOY-2.3%+1.7%
TTM-0.6%5Y-5.1%+4.5%
5Y-5.1%10Y-5.1%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.0%-3.8%+0.8%
TTM-0.6%-3.9%+3.3%
YOY-2.3%-4.7%+2.4%
5Y-5.1%-5.3%+0.2%
10Y-5.1%-5.8%+0.7%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Axonics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Axonics is operating .

  • Measures how much profit Axonics makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Axonics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.1%+0.1%
TTM-0.1%YOY-6.6%+6.5%
TTM-0.1%5Y-132.8%+132.7%
5Y-132.8%10Y-132.8%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--28.9%+28.9%
TTM-0.1%-12.9%+12.8%
YOY-6.6%-12.4%+5.8%
5Y-132.8%-19.1%-113.7%
10Y-132.8%-22.8%-110.0%
1.2.2. Operating Ratio

Measures how efficient Axonics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.41 means that the operating costs are €1.41 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Axonics Inc:

  • The MRQ is 1.410. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.270. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.410TTM1.270+0.140
TTM1.270YOY1.378-0.108
TTM1.2705Y2.726-1.456
5Y2.72610Y2.7260.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4101.422-0.012
TTM1.2701.432-0.162
YOY1.3781.430-0.052
5Y2.7261.416+1.310
10Y2.7261.380+1.346
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Axonics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Axonics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 9.96 means the company has €9.96 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Axonics Inc:

  • The MRQ is 9.962. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.059. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.962TTM12.059-2.098
TTM12.059YOY8.025+4.035
TTM12.0595Y10.605+1.455
5Y10.60510Y10.6050.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ9.9622.643+7.319
TTM12.0592.658+9.401
YOY8.0253.127+4.898
5Y10.6053.651+6.954
10Y10.6053.596+7.009
1.3.2. Quick Ratio

Measures if Axonics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • A Quick Ratio of 3.11 means the company can pay off €3.11 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Axonics Inc:

  • The MRQ is 3.114. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.952. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.114TTM5.952-2.838
TTM5.952YOY2.204+3.748
TTM5.9525Y2.295+3.657
5Y2.29510Y2.2950.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1141.385+1.729
TTM5.9521.489+4.463
YOY2.2041.921+0.283
5Y2.2952.331-0.036
10Y2.2952.575-0.280
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Axonics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Axonics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Axonics to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.12 means that Axonics assets are financed with 12.4% credit (debt) and the remaining percentage (100% - 12.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Axonics Inc:

  • The MRQ is 0.124. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.097. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.124TTM0.097+0.026
TTM0.097YOY0.137-0.040
TTM0.0975Y0.146-0.049
5Y0.14610Y0.1460.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1240.412-0.288
TTM0.0970.414-0.317
YOY0.1370.347-0.210
5Y0.1460.430-0.284
10Y0.1460.459-0.313
1.4.2. Debt to Equity Ratio

Measures if Axonics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • A Debt to Equity ratio of 14.1% means that company has €0.14 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Axonics Inc:

  • The MRQ is 0.141. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.108. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.141TTM0.108+0.033
TTM0.108YOY0.159-0.051
TTM0.1085Y0.175-0.067
5Y0.17510Y0.1750.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1410.560-0.419
TTM0.1080.599-0.491
YOY0.1590.495-0.336
5Y0.1750.612-0.437
10Y0.1750.682-0.507
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Axonics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Axonics generates.

  • Above 15 is considered overpriced but always compare Axonics to the Medical Devices industry mean.
  • A PE ratio of -45.65 means the investor is paying €-45.65 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Axonics Inc:

  • The EOD is -43.114. Based on the earnings, the company is expensive. -2
  • The MRQ is -45.650. Based on the earnings, the company is expensive. -2
  • The TTM is 105.337. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-43.114MRQ-45.650+2.536
MRQ-45.650TTM105.337-150.987
TTM105.337YOY321.566-216.229
TTM105.3375Y70.788+34.549
5Y70.78810Y70.7880.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-43.114-1.201-41.913
MRQ-45.650-1.737-43.913
TTM105.337-2.019+107.356
YOY321.566-2.507+324.073
5Y70.788-2.626+73.414
10Y70.788-1.915+72.703
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Axonics Inc:

  • The EOD is -67.019. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -70.961. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 36.290. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-67.019MRQ-70.961+3.942
MRQ-70.961TTM36.290-107.251
TTM36.290YOY-126.142+162.432
TTM36.2905Y-48.080+84.370
5Y-48.08010Y-48.0800.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-67.019-2.637-64.382
MRQ-70.961-3.428-67.533
TTM36.290-2.659+38.949
YOY-126.142-5.374-120.768
5Y-48.080-4.806-43.274
10Y-48.080-5.579-42.501
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Axonics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 5.57 means the investor is paying €5.57 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Axonics Inc:

  • The EOD is 5.256. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.565. Based on the equity, the company is overpriced. -1
  • The TTM is 4.878. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.256MRQ5.565-0.309
MRQ5.565TTM4.878+0.687
TTM4.878YOY6.072-1.194
TTM4.8785Y6.643-1.765
5Y6.64310Y6.6430.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD5.2562.113+3.143
MRQ5.5652.267+3.298
TTM4.8782.513+2.365
YOY6.0722.866+3.206
5Y6.6434.183+2.460
10Y6.6434.486+2.157
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Axonics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1890.228-183%0.511-137%0.596-132%0.596-132%
Book Value Per Share--11.32111.174+1%9.631+18%7.798+45%7.798+45%
Current Ratio--9.96212.059-17%8.025+24%10.605-6%10.605-6%
Debt To Asset Ratio--0.1240.097+27%0.137-10%0.146-15%0.146-15%
Debt To Equity Ratio--0.1410.108+30%0.159-11%0.175-19%0.175-19%
Dividend Per Share----0%-0%-0%-0%
Eps---0.345-0.021-94%-0.149-57%-0.231-33%-0.231-33%
Free Cash Flow Per Share---0.222-0.073-67%0.040-656%-0.163-27%-0.163-27%
Free Cash Flow To Equity Per Share---0.217-0.062-72%0.647-134%0.319-168%0.319-168%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--11.470--------
Intrinsic Value_10Y_min--9.430--------
Intrinsic Value_1Y_max---0.043--------
Intrinsic Value_1Y_min---0.043--------
Intrinsic Value_3Y_max--0.779--------
Intrinsic Value_3Y_min--0.725--------
Intrinsic Value_5Y_max--2.697--------
Intrinsic Value_5Y_min--2.425--------
Market Cap3035600750.000-6%3214165500.0002785610100.000+15%2955246612.500+9%2393573205.263+34%2393573205.263+34%
Net Profit Margin---0.209-0.047-78%-0.166-20%-1.421+580%-1.421+580%
Operating Margin----0.0010%-0.0660%-1.3280%-1.3280%
Operating Ratio--1.4101.270+11%1.378+2%2.726-48%2.726-48%
Pb Ratio5.256-6%5.5654.878+14%6.072-8%6.643-16%6.643-16%
Pe Ratio-43.114+6%-45.650105.337-143%321.566-114%70.788-164%70.788-164%
Price Per Share59.500-6%63.00054.600+15%57.925+9%46.916+34%46.916+34%
Price To Free Cash Flow Ratio-67.019+6%-70.96136.290-296%-126.142+78%-48.080-32%-48.080-32%
Price To Total Gains Ratio-314.953+6%-333.48044.944-842%124.284-368%-50.905-85%-50.905-85%
Quick Ratio--3.1145.952-48%2.204+41%2.295+36%2.295+36%
Return On Assets---0.027-0.006-79%-0.020-25%-0.041+55%-0.041+55%
Return On Equity---0.030-0.006-79%-0.023-23%-0.051+68%-0.051+68%
Total Gains Per Share---0.1890.228-183%0.511-137%0.596-132%0.596-132%
Usd Book Value--627112670.758618966493.175+1%533508880.240+18%431957363.834+45%431957363.834+45%
Usd Book Value Change Per Share---0.2050.247-183%0.555-137%0.647-132%0.647-132%
Usd Book Value Per Share--12.29212.132+1%10.457+18%8.467+45%8.467+45%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.375-0.023-94%-0.162-57%-0.251-33%-0.251-33%
Usd Free Cash Flow---12295268.031-4071588.759-67%2212798.238-656%-8060175.708-34%-8060175.708-34%
Usd Free Cash Flow Per Share---0.241-0.080-67%0.043-656%-0.177-27%-0.177-27%
Usd Free Cash Flow To Equity Per Share---0.236-0.067-72%0.702-134%0.346-168%0.346-168%
Usd Market Cap3296055294.350-6%3489940899.9003024615446.580+15%3208806771.853+9%2598941786.275+34%2598941786.275+34%
Usd Price Per Share64.605-6%68.40559.285+15%62.895+9%50.941+34%50.941+34%
Usd Profit---19112416.642-3988086.938-79%-11569752.215-39%-14086464.973-26%-14086464.973-26%
Usd Revenue--91410992.71696786609.902-6%73984612.829+24%54452239.665+68%54452239.665+68%
Usd Total Gains Per Share---0.2050.247-183%0.555-137%0.647-132%0.647-132%
 EOD+3 -5MRQTTM+8 -24YOY+13 -195Y+17 -1510Y+17 -15

3.2. Fundamental Score

Let's check the fundamental score of Axonics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-43.114
Price to Book Ratio (EOD)Between0-15.256
Net Profit Margin (MRQ)Greater than0-0.209
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.114
Current Ratio (MRQ)Greater than19.962
Debt to Asset Ratio (MRQ)Less than10.124
Debt to Equity Ratio (MRQ)Less than10.141
Return on Equity (MRQ)Greater than0.15-0.030
Return on Assets (MRQ)Greater than0.05-0.027
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Axonics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose62.000
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-03-312023-06-302023-09-302023-12-312024-03-31
Tax Provision  -743463-280-113-393-636-1,0304,5733,543



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets715,561
Total Liabilities88,462
Total Stockholder Equity627,099
 As reported
Total Liabilities 88,462
Total Stockholder Equity+ 627,099
Total Assets = 715,561

Assets

Total Assets715,561
Total Current Assets482,030
Long-term Assets233,531
Total Current Assets
Cash And Cash Equivalents 232,645
Short-term Investments 100,161
Net Receivables 50,529
Inventory 93,187
Other Current Assets 5,508
Total Current Assets  (as reported)482,030
Total Current Assets  (calculated)482,030
+/-0
Long-term Assets
Property Plant Equipment 17,037
Goodwill 98,543
Intangible Assets 78,422
Long-term Assets Other 39,529
Long-term Assets  (as reported)233,531
Long-term Assets  (calculated)233,531
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities48,387
Long-term Liabilities40,075
Total Stockholder Equity627,099
Total Current Liabilities
Accounts payable 15,770
Total Current Liabilities  (as reported)48,387
Total Current Liabilities  (calculated)15,770
+/- 32,617
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt31,610
Long-term Liabilities  (as reported)40,075
Long-term Liabilities  (calculated)31,610
+/- 8,465
Total Stockholder Equity
Total Stockholder Equity (as reported)627,099
Total Stockholder Equity (calculated)0
+/- 627,099
Other
Capital Stock5
Common Stock Shares Outstanding 51,018
Net Invested Capital 627,099
Net Working Capital 433,643
Property Plant and Equipment Gross 28,282



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
126,044
219,822
217,379
348,736
347,671
342,206
444,970
565,512
561,305
547,945
525,571
514,088
632,278
659,353
665,691
648,985
660,747
719,923
715,561
715,561719,923660,747648,985665,691659,353632,278514,088525,571547,945561,305565,512444,970342,206347,671348,736217,379219,822126,044
   > Total Current Assets 
117,824
211,680
204,065
335,505
334,458
327,946
228,372
332,183
330,229
321,317
307,433
313,127
449,361
465,075
469,671
455,396
475,385
491,422
482,030
482,030491,422475,385455,396469,671465,075449,361313,127307,433321,317330,229332,183228,372327,946334,458335,505204,065211,680117,824
       Cash And Cash Equivalents 
76,231
171,082
159,820
287,679
269,280
241,181
130,962
231,140
228,797
220,878
213,180
203,236
241,331
238,846
240,105
145,343
147,323
104,811
232,645
232,645104,811147,323145,343240,105238,846241,331203,236213,180220,878228,797231,140130,962241,181269,280287,679159,820171,08276,231
       Short-term Investments 
25,311
12,592
0
0
0
0
0
0
0
0
0
9,998
108,682
118,365
116,957
186,173
197,393
240,149
100,161
100,161240,149197,393186,173116,957118,365108,6829,99800000000012,59225,311
       Net Receivables 
954
8,779
21,670
15,015
18,550
18,270
21,509
25,646
26,641
29,044
27,425
36,115
36,960
44,817
40,200
47,436
48,944
57,243
50,529
50,52957,24348,94447,43640,20044,81736,96036,11527,42529,04426,64125,64621,50918,27018,55015,01521,6708,779954
       Inventory 
12,703
15,659
19,230
30,138
44,308
63,060
71,243
70,391
70,358
64,946
61,876
58,412
57,827
55,765
66,067
70,083
74,909
79,940
93,187
93,18779,94074,90970,08366,06755,76557,82758,41261,87664,94670,35870,39171,24363,06044,30830,13819,23015,65912,703
   > Long-term Assets 
8,220
8,142
13,314
13,231
13,213
14,260
216,598
233,329
231,076
226,628
218,138
200,961
182,917
194,278
196,020
193,589
185,362
228,501
233,531
233,531228,501185,362193,589196,020194,278182,917200,961218,138226,628231,076233,329216,59814,26013,21313,23113,3148,1428,220
       Property Plant Equipment 
0
7,247
6,106
12,362
12,392
13,428
12,948
12,658
12,568
14,015
13,707
13,828
7,103
6,798
7,017
6,349
6,556
10,760
17,037
17,03710,7606,5566,3497,0176,7987,10313,82813,70714,01512,56812,65812,94813,42812,39212,3626,1067,2470
       Goodwill 
0
0
0
0
0
0
87,382
106,631
109,565
105,510
102,558
94,852
86,942
94,414
96,581
98,880
95,287
99,417
98,543
98,54399,41795,28798,88096,58194,41486,94294,852102,558105,510109,565106,63187,382000000
       Intangible Assets 
0
0
282
0
0
0
115,023
113,416
108,302
106,469
101,179
91,627
81,787
86,253
85,888
85,543
80,274
81,375
78,422
78,42281,37580,27485,54385,88886,25381,78791,627101,179106,469108,302113,416115,02300028200
       Long-term Assets Other 
4,928
4,784
7,626
7,415
7,196
7,736
8,145
7,324
7,041
7,734
7,494
7,254
7,085
6,813
6,534
2,817
3,245
36,949
39,529
39,52936,9493,2452,8176,5346,8137,0857,2547,4947,7347,0417,3248,1457,7367,1967,4157,6264,7844,928
> Total Liabilities 
33,856
36,819
44,903
50,840
53,773
54,836
114,816
61,247
71,215
65,507
62,139
76,362
82,760
89,214
89,085
48,456
50,127
82,359
88,462
88,46282,35950,12748,45689,08589,21482,76076,36262,13965,50771,21561,247114,81654,83653,77350,84044,90336,81933,856
   > Total Current Liabilities 
15,543
12,033
19,847
30,829
38,816
45,682
24,046
24,387
27,751
26,868
25,519
29,859
60,843
65,247
66,170
32,084
35,593
45,816
48,387
48,38745,81635,59332,08466,17065,24760,84329,85925,51926,86827,75124,38724,04645,68238,81630,82919,84712,03315,543
       Short Long Term Debt 
6,382
0
5,000
10,000
15,000
21,110
22
30
109
0
0
0
0
32,600
0
0
0
0
0
0000032,6000000109302221,11015,00010,0005,00006,382
       Accounts payable 
4,232
5,882
7,440
10,728
9,415
10,660
11,446
9,447
10,512
7,654
10,390
10,207
9,972
9,070
14,737
12,185
14,666
18,452
15,770
15,77018,45214,66612,18514,7379,0709,97210,20710,3907,65410,5129,44711,44610,6609,41510,7287,4405,8824,232
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
30,500
32,600
34,400
0
0
0
0
000034,40032,60030,500000000000000
   > Long-term Liabilities 
18,313
24,786
25,056
20,011
14,957
9,154
90,770
36,860
43,464
38,639
36,620
46,503
21,917
23,967
22,915
16,372
14,534
36,543
40,075
40,07536,54314,53416,37222,91523,96721,91746,50336,62038,63943,46436,86090,7709,15414,95720,01125,05624,78618,313
       Long term Debt 
13,740
20,336
15,571
10,750
5,930
0
75,171
89
0
0
0
0
0
0
0
0
0
0
0
000000000008975,17105,93010,75015,57120,33613,740
       Capital Lease Obligations Min Short Term Debt
5,198
5,052
10,279
10,112
9,935
10,434
10,211
9,888
9,553
10,418
10,089
9,750
9,483
9,117
8,735
2,968
2,847
27,617
31,610
31,61027,6172,8472,9688,7359,1179,4839,75010,08910,4189,5539,88810,21110,4349,93510,11210,2795,0525,198
       Other Liabilities 
0
0
0
0
0
0
6,750
28,290
35,312
29,587
27,934
38,182
13,957
16,412
0
0
13,658
0
0
0013,6580016,41213,95738,18227,93429,58735,31228,2906,750000000
       Long-term Liabilities Other 
0
0
0
0
0
0
6,750
7,664
8,880
10,370
10,370
22,400
0
0
0
0
0
0
0
000000022,40010,37010,3708,8807,6646,750000000
> Total Stockholder Equity
92,188
183,003
172,476
297,896
293,898
287,370
330,154
504,265
490,090
482,438
463,432
437,726
549,518
570,139
576,606
600,529
610,620
637,564
627,099
627,099637,564610,620600,529576,606570,139549,518437,726463,432482,438490,090504,265330,154287,370293,898297,896172,476183,00392,188
   Common Stock
0
3
3
4
4
4
4
5
5
5
5
5
5
5
0
0
5
0
0
0050055555554444330
   Retained Earnings Total Equity0000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 00-24,51100-25,147-36,185-24,128-11,480-6,560-6,912-1,774-2,633-431-614-713-605-4280



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue366,379
Cost of Revenue-91,825
Gross Profit274,554274,554
 
Operating Income (+$)
Gross Profit274,554
Operating Expense-371,091
Operating Income-4,712-96,537
 
Operating Expense (+$)
Research Development34,886
Selling General Administrative235,316
Selling And Marketing Expenses-
Operating Expense371,091270,202
 
Net Interest Income (+$)
Interest Income17,314
Interest Expense--
Other Finance Cost-0
Net Interest Income17,314
 
Pretax Income (+$)
Operating Income-4,712
Net Interest Income17,314
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-8,74416,634
EBIT - interestExpense = 0
-6,088
-6,088
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--8,744
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-8,744
Tax Provision--2,656
Net Income From Continuing Ops-6,088-6,088
Net Income-6,088
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-21,346-17,314
 

Technical Analysis of Axonics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Axonics. The general trend of Axonics is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Axonics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Axonics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 62.00 < 62.00 < 62.00.

The bearish price targets are: 61.50 > 58.50 > 58.50.

Tweet this
Axonics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Axonics Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Axonics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Axonics Inc.

Axonics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAxonics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Axonics Inc. The current adx is .

Axonics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Axonics Inc.

Axonics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Axonics Inc.

Axonics Inc Daily Relative Strength Index (RSI) ChartAxonics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Axonics Inc.

Axonics Inc Daily Stochastic Oscillator ChartAxonics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Axonics Inc.

Axonics Inc Daily Commodity Channel Index (CCI) ChartAxonics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Axonics Inc.

Axonics Inc Daily Chande Momentum Oscillator (CMO) ChartAxonics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Axonics Inc.

Axonics Inc Daily Williams %R ChartAxonics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Axonics Inc.

Axonics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Axonics Inc.

Axonics Inc Daily Average True Range (ATR) ChartAxonics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Axonics Inc.

Axonics Inc Daily On-Balance Volume (OBV) ChartAxonics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Axonics Inc.

Axonics Inc Daily Money Flow Index (MFI) ChartAxonics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Axonics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-03-07 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25 00:00:00MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-26 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-04 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-08 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-10 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-13 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-22 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-23 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-24 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-28 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-31 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-03 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-04 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-06 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-12 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-24 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-25 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-27 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-01 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-05 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-17 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-18 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Axonics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Axonics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose62.000
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Axonics with someone you think should read this too:
  • Are you bullish or bearish on Axonics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Axonics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Axonics Inc

I send you an email if I find something interesting about Axonics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Axonics Inc.

Receive notifications about Axonics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.